Rates of gestational diabetes mellitus vary by state

Rates of gestational diabetes mellitus vary by state
Obesity, age, race/ethnicity, hospital characteristics, and insurance type may contribute to the variability in rates of gestational diabetes mellitus between states, according to research published in the May issue of Diabetes Care.

(HealthDay)—Obesity, age, race/ethnicity, hospital characteristics, and insurance type may contribute to the variability in rates of gestational diabetes mellitus (GDM) between states, according to research published in the May issue of Diabetes Care.

Barbara H. Bardenheier, Ph.D., M.P.H., of the U.S. in Atlanta, and colleagues analyzed data from the Healthcare Cost and Utilization Project State Inpatient Databases for 23 states to identify factors that contribute to variability in the rates of GDM between states.

The researchers found that rates of GDM per 100 deliveries, adjusted by age and by race, varied from 3.47 in Utah to 7.15 in Rhode Island. The major factors explaining the variability in GDM rates at the state level were the proportion of obese women (27.4 percent), hospital characteristics (17.6 percent), age (14.7 percent), race/ethnicity (11.8 percent), and insurance type (5.9 percent).

"Differences in GDM rates at the state level that are mostly driven by race/ethnicity, obesity, and hospital-level factors call for public health action," the authors write. "Our findings suggest that a large proportion of GDM could be avoided with prevention of among women of childbearing age."

More information: Abstract
Full Text (subscription or payment may be required)

add to favorites email to friend print save as pdf

Related Stories

BMI thresholds for gestational diabetes differ by race

Jun 01, 2012

(HealthDay) -- There is considerable racial/ethnic variation in the prevalence of gestational diabetes mellitus (GDM) by body mass index (BMI), according to a study published online May 22 in Diabetes Care.

Recommended for you

Personalised treatment for stress-related diabetes

Oct 14, 2014

Researchers at Lund University in Sweden are testing a treatment for type 2 diabetes which targets the disease mechanism itself - and not just the symptoms. For the first time, knowledge about the individual patient's genetic ...

Sensors to simplify diabetes management

Oct 13, 2014

For many patients diagnosed with diabetes, treating the disease can mean a burdensome and uncomfortable lifelong routine of monitoring blood sugar levels and injecting the insulin that their bodies don't ...

Androgen receptor signaling tied to insulin resistance

Oct 09, 2014

(HealthDay)—Mouse models show tissue-specific androgen receptor (AR) signaling is involved in regulation of metabolism, which may explain the link between androgen deprivation therapy (ADT) and the development ...

User comments